Iceca

Cefuroxime, the active ingredient in Iceca, is a cephalosporin presented as a sterile solution for intracameral use. It is employed to prevent postoperative endophthalmitis in patients undergoing intraocular surgery.

GNH USA supplies Iceca as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Cefuroxime is a broad‑spectrum cephalosporin used in the intraocular setting to reduce infection risk after surgery.

- Postoperative endophthalmitis: prevention of bacterial infection following cataract or other intraocular procedures.

Cefuroxime administered intracamerally may be associated with ocular and systemic reactions.

Common Side Effects: - Mild ocular irritation: transient discomfort at the injection site. - Conjunctival hyperemia: temporary redness of the eye. - Mild anterior chamber inflammation: low‑grade cellular reaction. - Temporary visual blur: short‑term decrease in visual acuity. - Mild headache: occasional post‑procedure headache. - Nausea: occasional feeling of nausea after injection.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis requiring emergency care. - Endophthalmitis despite prophylaxis: rare breakthrough infection. - Persistent intraocular inflammation: prolonged uveitis. - Retinal toxicity: rare vision‑threatening retinal damage. - Systemic hypersensitivity: rash, fever, or hypotension. - Acute renal impairment: rare in susceptible patients.

Cefuroxime should be used with attention to patient history and handling requirements.

- Allergy assessment: confirm no known hypersensitivity to cephalosporins or beta‑lactams. - Renal function: evaluate in patients with impaired kidney function, adjust if necessary. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk. - Ocular surgery protocol: follow aseptic technique and recommended dosing guidelines. - Monitoring: observe for signs of intraocular inflammation or allergic reaction after administration. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Cefuroxime may interact with other agents that affect renal clearance or hypersensitivity risk.

Major Interactions (Avoid): - Aminoglycosides: increased risk of nephrotoxicity when combined. - Loop diuretics: may potentiate renal impairment. - Other beta‑lactam antibiotics: heightened risk of cross‑reactive allergic reactions.

Moderate Interactions (Monitor Closely): - NSAIDs: monitor renal function when used concurrently. - Anticoagulants: observe for altered bleeding risk due to potential platelet effects. - Probenecid: may increase cefuroxime plasma levels, requiring dose review.